The first shipment of YHLO iFlash 1200 to Latin America set sail
Time Posted ：2024-04-07
World Heart Day 29 September 2021: Beating Cardiovascular Disease in COVID-19 Times
Time Posted ：2024-04-07
The heart is one of our most important organs because it provides our cells with oxygen and nutrients and removes waste. Any signs of heart problems should be taken seriously because it is related to longevity and survival. It is important to eat correctly, exercise, stay away from smoking and alcohol, and avoid junk food to avoid heart disease.
View Details
World Arthritis Day 12 Oct 2021: Don't Delay, Healthy Every Day
Time Posted ：2024-04-07
World Thrombosis Day 13 October 2021: Reduce APS Knowledge Gap
Time Posted ：2024-04-03
Antiphospholipid syndrome (APS) is linked to one-third of new strokes occurring in individuals younger than 50 years, and may be responsible for up to 1% of all thrombosis. APS is a life-threatening systemic autoimmune disease that causes excessive blood clotting. Immune system mistakenly produces antibodies (antiphospholipid antibodies [aPL]) against certain normal proteins in the blood. These antibodies can cause potentially fatal events such as strokes, heart attacks, and blood clots in the legs (deep vein thrombosis) and lungs (pulmonary embolism). Antiphospholipid Syndrome is the most important treatable cause of recurrent miscarriage; it is also associated with other pregnancy complications such as pre-eclampsia, low weight babies, and premature births. Despite increased recognition of APS, much remains to be learned about the cause, full range of symptoms, diagnosis, and treatment for APS. APS can be detected by antiphospholipid (aPL) antibodies, including lupus anticoagulant (LA), anticardiolipin (aCL) antibody, and/or anti-β2 glycoprotein I (aβ2 GPI) antibody assays. APL antibodies can assist the determination of the risk of thrombotic and obstetric events, and consequently the intensity of treatment.
View Details
YHLO launched its latest iFlash integrated system at CMEF, reaching new milestone with our persistence in R&D
Time Posted ：2024-04-03
October 13, 2021, Shenzhen, China, YHLO grandly showed up at the China International Medical Equipment Fair(CMEF), brought another new high-end product iFlash 9000 to the spotlight.
CMEF is recognized as the largest scale and most well-know expo fair in China for MedTech, it attracts over 100,000 professional visitors to participate every year. Annually numbers of enterprises, dealers and agencies , medical doctors and experts, etc. are joining together in this big event from all over the world.
View Details
Add: Building 1, YHLO Biopark, Baolong 2nd Road, Baolong Subdistrict, Longgang District, 518116 Shenzhen, P.R.China
